Pandemrix vaccine: why was the public not told of early warning signs?
PublisherBMJ Publishing Group
MetadataShow full item record
AbstractEight years after the pandemic influenza outbreak, a lawsuit alleging that GlaxoSmithKline’s Pandemrix vaccine caused narcolepsy has unearthed internal reports suggesting problems with the vaccine’s safety. Peter Doshi asks what this means for the future of transparency during public health emergencies.
CitationDoshi, P. (2018). Pandemrix vaccine: why was the public not told of early warning signs? BMJ, 362:k3948. doi: 10.1136/bmj.k3948
Influenza Vaccines--adverse effects
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/8270
The following license files are associated with this item: